Overview The FDA has added a Strategic Priorities initiative that can assist companies to proactively address areas of GMP concern. This webinar discusses their latest / second Priorities, for the period of 2014 through 2018. It will address the major shift in the emphasis of the U.S. FDA cGMP compliance audits, clinical trial phases, product submissions and company response requirements. All regulatory areas are under evaluation by the FDA, and need to be revisited by a company's QA/RA and its senior management.

Date : 10th March 2015 to 10th March 2015

Place : United States, New hyde park

Website :https://www.complianceglobal.us/product/700009

Contact Person:Compliance Global Inc

Description:

Overview The FDA has added a "Strategic Priorities" initiative that can assist companies to proactively address areas of GMP concern. This webinar discusses their latest / second “Priorities”, for the period of 2014 through 2018. It will address the major shift in the emphasis of the U.S. FDA cGMP compliance audits, clinical trial phases, product submissions and company response requirements. All regulatory areas are under evaluation by the FDA, and need to be revisited by a company's QA/RA and its senior management.

Overview The FDA has added a Strategic Priorities initiative that can assist companies to proactively address areas of GMP concern. This webinar discusses their latest / second Priorities, for the period of 2014 through 2018. It will address the major shift in the emphasis of the U.S. FDA cGMP compliance audits, clinical trial phases, product submissions and company response requirements. All regulatory areas are under evaluation by the FDA, and need to be revisited by a company's QA/RA and its senior management. will be held in New hyde park,United States on date 2015-03-10

---

Deadline for abstracts/proposals : 10th March 2015

Keynote Speakers :

Check the event website for more details.